impact factor
logo
 

One year in review

 

Fibromyalgia: one year in review 2022


1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, Italy. vale.gio@fastwebnet.it
  2. Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, and Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  3. Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, Italy.
  4. Rheumatology Unit, ATS Sardegna, P. Dettori Hospital, Tempio Pausania, Italy.
  5. Department of Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  6. Rheumatology Clinic, Ospedale Carlo Urbani, Università Politecnica delle Marche, Jesi, Ancona, Italy.
  7. Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, and Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

CER15762
2022 Vol.40, N°6
PI 1065, PF 1072
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 35748720 [PubMed]

Received: 10/04/2022
Accepted : 28/04/2022
In Press: 22/06/2022
Published: 22/06/2022

Abstract

Fibromyalgia syndrome (FM) is a chronic widespread pain syndrome characterised by fatigue, sleep disturbances and many idiopathic pain symptoms. The aim of this review is to describe and summarise the most recent findings concerning the diagnosis, aetiopathogenesis and treatment of fibromyalgia syndrome published between January 2021 and January 2022 and appearing on PubMed database. In particular, last year’s literature focused on the impact of COVID-19 pandemic on FM patients, on new aetiopathogenetic horizons and the last conclusions about pharmacological and non-pharmacological interventions.

DOI: https://doi.org/10.55563/clinexprheumatol/if9gk2

Rheumatology Article